Outcomes of Treatment of Nonagenarians With Severe Aortic Stenosis
Conclusions Treatment of AS approximates natural life expectancy in select nonagenarians, with no significant difference in long-term survival between SAVR and TAVR. Importantly, patient quality of life improved at 1 year. With appropriate selection, nonagenarians with severe AS can benefit from treatment.
Source: The Annals of Thoracic Surgery - Category: Cardiovascular & Thoracic Surgery Source Type: research
More News: Aortic Stenosis | Cardiology | Cardiomyopathy | Cardiovascular & Thoracic Surgery | Heart | Heart Valve Surgery | Stroke